CYTARABINE-INDUCED KERATOCONJUNCTIVITIS: A COMMON COMPLICATION OF HIGH DOSE THERAPY FOR ACUTE MYELOID LEUKEMIA

Katherine Schmidt

Full Outline

Download Full Outline

Abstract

Here we describe a case of cytarabine ocular toxicity in a patient with acute myeloid leukemia. Keratoconjunctivitis is a well-described side effect in the hematology/oncology literature. Prophylactic topical steroids are typically initiated, with variable efficacy.

Details

Year: 2016

Program Number: R2016168

Author Affiliation: New England College of Optometry

Co-Authors: n/a

Co-Author Affiliation: n/a

Room: Ballroom A-B